Neocarzinostatin: initial clinical and pharmacologic studies in the United States.
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D006801:Humans; D007700:Kinetics; D009369:Neoplasms / Q000188:drug therapy*; D013997:Time Factors; D014481:United States; D009353:Zinostatin / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D009353:Zinostatin